[Sepsis in the Intermediate Respiratory Care Unit: Restrospective Study] [0.03%]
[ intermediate护理单元的脓毒症：回顾性研究]
Fernando Garcia Prieto,Daniel López Padilla,Diego Durán Barata et al.
Fernando Garcia Prieto et al.
Introduction: Sepsis is a dysregulated response to infection that can lead to organ dysfunction and requires urgent management. Advanced respiratory support (high-flow oxygen therapy and/or non-invasive mechanical ventila...
Pulmonary Mass as a Rare Pulmonary Manifestation of Inflammatory Bowel Disease [0.03%]
炎症性肠病的一种罕见肺表现：肺部肿物
María Conejero Merchán,Jorge Mora Pinilla,Natalia Ruiz Aguilera et al.
María Conejero Merchán et al.
Pulmonary involvement in inflammatory bowel disease (IBD) is rare, particularly as parenchymal lesions such as masses. We report a 42-year-old woman with recently diagnosed Crohn's disease, not on active treatment, who presented with pleuri...
[BioSAT: Development and conceptual validation of a satisfaction questionnaire regarding biologic therapies for severe asthma through a structured patient-professional co-creation process] [0.03%]
[_bioSAT：通过结构化患者-专业人员协同创作过程开发并概念验证针对重度哮喘生物制剂治疗满意度问卷]
Francisco Javier Álvarez-Gutiérrez,Marina Blanco Aparicio,Francisco Casas Maldonado et al.
Francisco Javier Álvarez-Gutiérrez et al.
Introduction: The benefits of biologic therapies in severe uncontrolled asthma (SUA) have primarily focused on clinical and lung function variables. However, other patient-relevant dimensions, such as confidence in treatm...
Nintedanib in a Dialysis Patient with Idiopathic Pulmonary Fibrosis: A One-Year Follow-Up Without Major Adverse Events [0.03%]
一例接受血液透析治疗的特发性肺纤维化患者的尼达尼布1年随访：无严重不良事件
Cristina Matesanz-López,María Asunción Nieto-Barbero
Cristina Matesanz-López
The Future of New Inhaled Phosphodiesterase Inhibitors in Chronic Obstructive Pulmonary Disease [0.03%]
慢性阻塞性肺疾病中新型吸入型磷酸二酯酶抑制剂的未来展望
Antonio Anzueto
Antonio Anzueto
[2027: A new year for a new epidemiological study of chronic obstructive pulmonary disease in Spain] [0.03%]
2027：西班牙慢性阻塞性肺疾病流行病学的新一年
Joan B Soriano,Marc Miravitlles,José Luis López-Campos et al.
Joan B Soriano et al.
A real opportunity exists to conduct a fourth epidemiological study of COPD in Spain by 2027, continuing the trilogy begun with IBERPOC (1997), EPISCAN (2007), and EPISCAN II (2017). These previous studies have been fundamental to understan...
Javier Bayo,Carlos Baeza-Martínez,Gerardo Pulido-Reyes et al.
Javier Bayo et al.
Bilioptysis as a Diagnostic Cornerstone for Occult Bronchobiliary Fistula [0.03%]
隐匿性支气管胆瘘的诊断基石——柏油样痰
Marwan Mohamed Choukri
Marwan Mohamed Choukri
Bilioptysis is a rare clinical entity characterized by the expectoration of biliary secretions through the respiratory tract. Its presence is pathognomonic of a biliopulmonary or bronchobiliary fistula. We present the case of a 69-year-old ...
Specialized Asthma Care Units in Spain: Limited Awareness; Strong Support [0.03%]
西班牙的哮喘专科护理单元：认知度有限；支持度高
Francisco Javier Alvarez-Gutiérrez,Francisco Casas-Maldonado,José Gregorio Soto-Campos et al.
Francisco Javier Alvarez-Gutiérrez et al.
The EXACERBANTES Study (Exacerbation of Chronic Obstructive Pulmonary Disease According to the ANTES Proposal): Rationale, Goals and Design [0.03%]
EXACERBANTES研究（慢性阻塞性肺疾病急性加重的ANTES方案评估）：立题依据、目的及设计
Juan José Soler-Cataluña,Alberto Fernández-Villar,José Luis Izquierdo et al.
Juan José Soler-Cataluña et al.
Introduction: COPD exacerbations (ECOPD) are complex events that demand a personalized approach. A novel patient-centered approach focuses on the identification of treatable traits (TTs) has recently been proposed. ...